Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krainer

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|June 11, 1997
Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitroA C Budinsky, T Brodowicz, C Wiltschke, et al.
Oncology|December 12, 1997
Tissue expression and serum levels of HER-2/neu in patients with breast cancerM Krainer, T Brodowicz, R Zeillinger, et al.
Urology|June 7, 2000
Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapyM Krainer, H M Wolf, C Wiltschke, et al.
Hellenic Journal of Nuclear Medicine|January 12, 2018
Hematopoiesis is prognostic for toxicity and survival of <sup>223</sup>Radium treatment in patients with metastatic castration-resistant prostate cancerA Leisser, M Nejabat, M Hartenbach, et al.
Cancer Genetics and Cytogenetics|August 25, 2001
High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinomaI Pribill, P Speiser, J Leary, et al.
Cancer|January 15, 1995
Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of diseaseM Krainer, H Wolf, I Michl, et al.
Cancer|January 1, 1994
Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancerC Wiltschke, E Tyl, P Speiser, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Soluble ICAM-1 in breast cancer: clinical significance and biological implicationsW J Köstler, S Tomek, T Brodowicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeastC Ishioka, T Suzuki, M FitzGerald, et al.
British Journal of Cancer|June 1, 1995
Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal studyC Wiltschke, M Krainer, A C Budinsky, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|June 11, 1997
Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitroA C Budinsky, T Brodowicz, C Wiltschke, et al.
Oncology|December 12, 1997
Tissue expression and serum levels of HER-2/neu in patients with breast cancerM Krainer, T Brodowicz, R Zeillinger, et al.
Urology|June 7, 2000
Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapyM Krainer, H M Wolf, C Wiltschke, et al.
Hellenic Journal of Nuclear Medicine|January 12, 2018
Hematopoiesis is prognostic for toxicity and survival of <sup>223</sup>Radium treatment in patients with metastatic castration-resistant prostate cancerA Leisser, M Nejabat, M Hartenbach, et al.
Cancer Genetics and Cytogenetics|August 25, 2001
High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinomaI Pribill, P Speiser, J Leary, et al.
Cancer|January 15, 1995
Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of diseaseM Krainer, H Wolf, I Michl, et al.
Cancer|January 1, 1994
Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancerC Wiltschke, E Tyl, P Speiser, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Soluble ICAM-1 in breast cancer: clinical significance and biological implicationsW J Köstler, S Tomek, T Brodowicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeastC Ishioka, T Suzuki, M FitzGerald, et al.
British Journal of Cancer|June 1, 1995
Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal studyC Wiltschke, M Krainer, A C Budinsky, et al.
Pageof 5